Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.608
+0.016 (2.77%)
At close: May 1, 2024, 4:00 PM
0.591
-0.017 (-2.80%)
After-hours: May 1, 2024, 6:19 PM EDT

Ensysce Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020201920182017
Market Capitalization
43611478261246248
Market Cap Growth
--39.77%-95.14%46.40%-70.11%6.11%-0.91%-
Enterprise Value
43711982263244246
PE Ratio
-0.31-0.31-0.22-3.811371.67-25.79115.69-7942.49
PB Ratio
-10.33-10.33-1.49-14.47-12.09-39.0249.1049.55
P/FCF Ratio
-0.31-0.31-0.31-13.83-62.43-278.53-198.26-983.79
P/OCF Ratio
-0.31-0.31-0.31-13.83-62.43-278.53-198.26-983.79
EV/EBITDA Ratio
-0.30-0.30-0.28-4.2877.86-28.7491.12-8914.29
EV/EBIT Ratio
-0.30-0.30-0.28-4.2877.88-28.7491.12-8914.29
EV/FCF Ratio
-0.28-0.28-0.38-14.43-65.70-280.97-196.92-975.50
Debt / Equity Ratio
-2.65-2.65-1.19-2.19-0.66-0.39--
Debt / EBITDA Ratio
-0.08-0.08-0.18-0.624.06-0.29--
Debt / FCF Ratio
-0.08-0.08-0.25-2.09-3.42-2.80--
Quick Ratio
0.370.370.360.770.030.073.7913.38
Current Ratio
0.690.690.560.950.050.094.3814.77
Interest Coverage
-28.99-28.99-219.70-21.451.06-9.53--
Return on Equity (ROE)
-780.20%-780.20%1126.20%1213.10%2.70%-485.50%42.40%-
Return on Assets (ROA)
-262.40%-262.40%-290.90%-327.40%0.30%-6.50%1.00%-
Return on Capital (ROIC)
-2015.31%-2015.31%-3365.91%-212.84%74.34%211.31%-15.21%-2.93%
Earnings Yield
-238.46%-318.64%-453.03%-26.22%0.07%-3.88%0.86%-0.01%
FCF Yield
-241.91%-323.25%-322.96%-7.23%-1.60%-0.36%-0.50%-0.10%
Buyback Yield / Dilution
-1158.34%-1158.34%-114.15%-22.15%33.68%-314.69%2.94%-
Total Shareholder Return
-1158.34%-1158.34%-114.15%-22.15%33.68%-314.69%2.94%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).